Supply Chain Challenges Facing Ambulatory Surgical Centers in 2026

Ambulatory Surgical Centers (ASCs) are confronting a series of supply chain challenges in 2026, with significant issues arising from drug shortages, increased tariffs, and changes in reimbursement policies. These factors are contributing to higher material costs and operational difficulties across the healthcare sector.

Drug Shortages and Tariff Impacts

One of the most pressing issues for ASCs is the national drug shortage affecting approximately 250 medications. Injectable drugs are particularly impacted, creating substantial backorder situations that complicate patient care and treatment protocols. This shortage is exacerbated by increasing tariffs on foreign-made medical goods, which are driving up costs across the board.

The European Union has implemented a cap on pharmaceutical export tariffs at 15%, while Japan has exempted generic drugs from its tariffs. Despite these measures, the overall cost of importing medical goods remains high, placing additional financial strain on ASCs.

Reimbursement and Regulatory Challenges

In addition to supply chain disruptions, ASCs are facing regulatory changes that threaten their financial stability. A significant policy shift involves the elimination of reimbursement for skin substitutes under Medicare payment schedules, which could disrupt wound care practices. This change is part of broader modifications to the Medicare payment system that could further complicate ASC operations.

Operational and Management Difficulties

Many ASCs are grappling with critical supply chain problems, partly due to the lack of dedicated materials managers. The absence of specialized personnel to oversee supply chain logistics has led to inefficiencies and increased vulnerability to disruptions. To mitigate these challenges, ASCs are increasingly adopting software solutions for inventory management.

While the implementation of inventory management software has seen moderate success, ASCs continue to rely heavily on just-in-time delivery services to ensure the timely arrival of essential medical supplies. This dependency has prompted ASCs to request real-time inventory access from suppliers, fostering greater collaboration between manufacturers and distributors.

Future Outlook and Adaptation Strategies

Looking ahead, supply chain disruptions are expected to persist throughout 2026, necessitating ongoing adaptation and strategic planning by ASCs. The increased collaboration between manufacturers and distributors is a positive development, offering potential pathways to mitigate some of the challenges posed by drug shortages and tariff-related cost increases.

ASCs are actively seeking innovative solutions to navigate these complexities, focusing on technology integration and improved supply chain management practices. As the healthcare landscape evolves, ASCs will need to remain agile and responsive to continue delivering quality care amidst these logistical hurdles.